Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: Motilal Oswal Securities Ltd.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lupin Ltd launches generic Trilipix delayed‐release capsules 45 mg & 135 mg  in US 

Thursday, 5 Dec 2013 10:49pm EST 

Lupin Ltd:Says that its US subsidiary, Lupin Pharmaceuticals, Inc. has launched its generic Fenofibric Acid Delayed‐Release Capsules 45 mg and 135 mg.Says it had earlier received final approval from the US FDA for the same. 

Company Quote

-0.3 -0.02%
6:29am EDT